Berlin - The new chairman of the board of the (KBV) has lot of approval from the system of the statutory health insurance associations (KV) and from independent medical associations. “We warmly congratulate Mr. Gassen on his new position. He was the designated candidate for the specialists in the representative assembly and it was important that he was elected with clear majority, ”said Werner Baumgärtner's CEO.
Looking to the future, he would like that Gassen continued the fee policy towards fixed and reasonable prices. He also hopes for the support of the KBV top in the development of general practitioner and specialist contracts outside of the KV system: "We need an orderly cooperation between the two contract worlds in order to improve the framework conditions for private practices," said Medi-Geno -Chairman. At the moment, practices that participate in selective contracts are being disadvantaged by the rules governing adjustment in the individual KVs, he criticized.
She is hoping for constructive cooperation between general practitioners and specialists within the KBV: "After Mr. Gassen As is well known, he followed the 'plea for turning away from camp thinking' and the KBV representative assembly voted with clear majority against sectoralization of the executive and legislative branches according to supply areas , it said from the KV.
The congratulations go in the same direction: “One of Gassen's tasks will be to give the KBV its original politi reflect the weight that has suffered greatly in recent months due to the dispute between the various groups, ”said NAV chairman Dirk Heinrich. All of these groups would have to contribute to this, however, and committed themselves to uniform joint KV system, said Heinrich.
The central association ZNS (SPiZ) referred to Gassen's professional experience. "With Gassen, colleague who is experienced and competent not only in medical professional policy but also in medical self-administration has been elected to the top of the KBV, who, with assertiveness and political skill, has good prerequisites to lead the KBV's business responsibly in the future", said the SPiZ chairman Frank Bergmann.
Congratulations also came from the (SpiFa), which Gassen has directed so far. "Under the leadership of Andreas Gassen, who was elected KBV CEO, the SpiFa expects clear medical voice, emphasis and problem-solving skills in relation to politics and the health insurers," explained SpiFa Managing Director Lars Lindemann.